Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

PCI Expands Controlled Substance Storage Facility

Supports DEA Schedule I-V controlled substances for both commercial prescription medicines, as well as those for investigational clinical trials.

Biopharmaceutical services provider PCI Pharma Services (PCI) has further invested in its infrastructure for packaging of controlled substances, complementing its capacity for blister packaging, a key tenet of recent calls for dispensing opioid prescriptions in limited-quantity unit-dose packaging as a tactic to combat substance misuse.

PCI has extended onsite controlled substance storage at its U.S. commercial packaging locations in Philadelphia, PA and Rockford, IL, and will undertake further expansions as demand increases for these specialized requirements. PCI supports DEA Schedule I-V controlled substances for both commercial prescription medicines, as well as those for investigational clinical trials, with approximately two million sq-ft of dedicated packaging infrastructure across the two locations.

Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report